PRME
Prime Medicine, Inc. · Healthcare
10% owner Gv 2019 Gp, L.L.C. sold $5.9M of Prime Medicine, Inc.
Sold$5,946,340
$14.09Price
422,010Shares
−3%Stake
What PRME did after the filing
- The stock from Wed, May 10 close, $14.04
- +6.8%
- S&P 500, same days
- +5.3%
Measured over 30 trading days, to the Jun 23 close.
Traded Mon, May 8. Filed Wed, May 10, 12:17 PM ET, during the session. Returns use the May 10 close and the Jun 23 close. Not investment advice.